Global Autoimmune Disease Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028

Description

List of Tables

Value Market Research deeply researched the Global Autoimmune Disease Diagnostics Market to foresee a significant growth in the industry over the upcoming years. The global autoimmune disease diagnostics market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global autoimmune disease diagnostics market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this autoimmune disease diagnostics market.

The next sections of the autoimmune disease diagnostics market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below-

By Diseases

Rheumatoid Arthritis

Celiac Disease

Inflammatory Bowel Disease

Systemic Lupus Erythematosus

Multiple Sclerosis

Sjogren´s Syndrome

Antiphospholipid Syndrome

Autoimmune Liver Disease

Vasculitis And Others

By Product

Consumables & Assay Kits

Instruments

By Type

Localized Autoimmune Disease Diagnostic

Systemic Autoimmune Disease Diagnostic

By Technology

Bridge Therapy

Topical Therapy

Disease-modifying Antirheumatic Drugs (DMARD)

Phototherapy

Helminthic Therapy

Recombinant Technology And Others

By Test Type

Anti-nuclear Antibody

Enzyme-linked Immunosorbent Assay

ESR/CRP

IFA/Anti-neutrophil Cytoplasmic Antibodies (ANCA)

Multiplex

Dot-Blot And Others

Product Code: VMR11214429

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . AUTOIMMUNE DISEASE DIAGNOSTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Diseases
- 3.7.2 Market Attractiveness Analysis By Product
- 3.7.3 Market Attractiveness Analysis By Type
- 3.7.4 Market Attractiveness Analysis By Technology
- 3.7.5 Market Attractiveness Analysis By Test Type
- 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

5.1. Impact Analysis of Covid-19 Outbreak
- 5.1.1. Direct Impact on Production
- 5.1.2. Supply Chain and Market Disruption
- 5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ANALYSIS BY DISEASES

6.1 Overview by Diseases
6.2 Historical and Forecast Data
6.3 Analysis by Diseases
6.4 Rheumatoid Arthritis Historic and Forecast Sales by Regions
6.5 Celiac Disease Historic and Forecast Sales by Regions
6.6 Inflammatory Bowel Disease Historic and Forecast Sales by Regions
6.7 Systemic Lupus Erythematosus Historic and Forecast Sales by Regions
6.8 Multiple Sclerosis Historic and Forecast Sales by Regions
6.9 Sjogren´s Syndrome Historic and Forecast Sales by Regions
6.10. Antiphospholipid Syndrome Historic and Forecast Sales by Regions
6.11 Autoimmune Liver Disease Historic and Forecast Sales by Regions
6.12 Vasculitis And Others Historic and Forecast Sales by Regions

7 . GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ANALYSIS BY PRODUCT

7.1 Overview by Product
7.2 Historical and Forecast Data
7.3 Analysis by Product
7.4 Consumables & Assay Kits Historic and Forecast Sales by Regions
7.5 Instruments Historic and Forecast Sales by Regions

8 . GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ANALYSIS BY TYPE

8.1 Overview by Type
8.2 Historical and Forecast Data
8.3 Analysis by Type
8.4 Localized Autoimmune Disease Diagnostic Historic and Forecast Sales by Regions
8.5 Systemic Autoimmune Disease Diagnostic Historic and Forecast Sales by Regions

9 . GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY

9.1 Overview by Technology
9.2 Historical and Forecast Data
9.3 Analysis by Technology
9.4 Bridge Therapy Historic and Forecast Sales by Regions
9.5 Topical Therapy Historic and Forecast Sales by Regions
9.6 Disease-modifying Antirheumatic Drugs (DMARD) Historic and Forecast Sales by Regions
9.7 Phototherapy Historic and Forecast Sales by Regions
9.8 Helminthic Therapy Historic and Forecast Sales by Regions
9.9 Recombinant Technology And Others Historic and Forecast Sales by Regions

10 . GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE

10.1 Overview by Test Type
10.2 Historical and Forecast Data
10.3 Analysis by Test Type
10.4 Anti-nuclear Antibody Historic and Forecast Sales by Regions
10.5 Enzyme-linked Immunosorbent Assay Historic and Forecast Sales by Regions
10.6 ESR/CRP Historic and Forecast Sales by Regions
10.7 IFA/Anti-neutrophil Cytoplasmic Antibodies (ANCA) Historic and Forecast Sales by Regions
10.8 Multiplex Historic and Forecast Sales by Regions
10.9 Dot-Blot And Others Historic and Forecast Sales by Regions

11 . GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

11.1. Top Company Share Analysis
11.2. Introduction
11.3. North America Sales Analysis
- 11.3.1. Overview, Historic and Forecast Sales Analysis
- 11.3.2. North America By Segment Sales Analysis
- 11.3.3. North America By Country Sales Analysis
- 11.3.4. United State Sales Analysis
- 11.3.5. Canada Sales Analysis
- 11.3.6. Mexico Sales Analysis
11.4. Europe Sales Analysis
- 11.4.1. Overview, Historic and Forecast Sales Analysis
- 11.4.2. Europe by Segment Sales Analysis
- 11.4.3. Europe by Country Sales Analysis
- 11.4.4. United Kingdom Sales Analysis
- 11.4.5. France Sales Analysis
- 11.4.6. Germany Sales Analysis
- 11.4.7. Italy Sales Analysis
- 11.4.8. Russia Sales Analysis
- 11.4.9. Rest Of Europe Sales Analysis
11.5. Asia Pacific Sales Analysis
- 11.5.1. Overview, Historic and Forecast Sales Analysis
- 11.5.2. Asia Pacific by Segment Sales Analysis
- 11.5.3. Asia Pacific by Country Sales Analysis
- 11.5.4. China Sales Analysis
- 11.5.5. India Sales Analysis
- 11.5.6. Japan Sales Analysis
- 11.5.7. South Korea Sales Analysis
- 11.5.8. Australia Sales Analysis
- 11.5.9. Rest Of Asia Pacific Sales Analysis
11.6. Latin America Sales Analysis
- 11.6.1. Overview, Historic and Forecast Sales Analysis
- 11.6.2. Latin America by Segment Sales Analysis
- 11.6.3. Latin America by Country Sales Analysis
- 11.6.4. Brazil Sales Analysis
- 11.6.5. Argentina Sales Analysis
- 11.6.6. Peru Sales Analysis
- 11.6.7. Chile Sales Analysis
- 11.6.8. Rest of Latin America Sales Analysis
11.7. Middle East & Africa Sales Analysis
- 11.7.1. Overview, Historic and Forecast Sales Analysis
- 11.7.2. Middle East & Africa by Segment Sales Analysis
- 11.7.3. Middle East & Africa by Country Sales Analysis
- 11.7.4. Saudi Arabia Sales Analysis
- 11.7.5. UAE Sales Analysis
- 11.7.6. Israel Sales Analysis
- 11.7.7. South Africa Sales Analysis
- 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE AUTOIMMUNE DISEASE DIAGNOSTICS COMPANIES

12.1. Autoimmune Disease Diagnostics Market Competition
12.2. Partnership/Collaboration/Agreement
12.3. Merger And Acquisitions
12.4. New Product Launch
12.5. Other Developments

13 . COMPANY PROFILES OF AUTOIMMUNE DISEASE DIAGNOSTICS INDUSTRY

13.1. Company Share Analysis
13.2. Market Concentration Rate
13.3. AESKU Diagnostics GMBH & Co KG
- 13.3.1. Company Overview
- 13.3.2. Company Revenue
- 13.3.3. Products
- 13.3.4. Recent Developments
13.4. Binding Site Group (BSG)
- 13.4.1. Company Overview
- 13.4.2. Company Revenue
- 13.4.3. Products
- 13.4.4. Recent Developments
13.5. Biomerica
- 13.5.1. Company Overview
- 13.5.2. Company Revenue
- 13.5.3. Products
- 13.5.4. Recent Developments
13.6. DiaSorin
- 13.6.1. Company Overview
- 13.6.2. Company Revenue
- 13.6.3. Products
- 13.6.4. Recent Developments
13.7. EuroImmun
- 13.7.1. Company Overview
- 13.7.2. Company Revenue
- 13.7.3. Products
- 13.7.4. Recent Developments
13.8. HOB Biotech Group
- 13.8.1. Company Overview
- 13.8.2. Company Revenue
- 13.8.3. Products
- 13.8.4. Recent Developments
13.9. INOVA Diagnostics
- 13.9.1. Company Overview
- 13.9.2. Company Revenue
- 13.9.3. Products
- 13.9.4. Recent Developments
13.10. Orgentec Diagnostika
- 13.10.1. Company Overview
- 13.10.2. Company Revenue
- 13.10.3. Products
- 13.10.4. Recent Developments
13.11. ROCHE Diagnostics
- 13.11.1. Company Overview
- 13.11.2. Company Revenue
- 13.11.3. Products
- 13.11.4. Recent Developments
13.12. SIEMENS Healthhinners GMBH
- 13.12.1. Company Overview
- 13.12.2. Company Revenue
- 13.12.3. Products
- 13.12.4. Recent Developments
13.13. Thermo Fisher
- 13.13.1. Company Overview
- 13.13.2. Company Revenue
- 13.13.3. Products
- 13.13.4. Recent Developments
13.14. TOSOH Bioscience
- 13.14.1. Company Overview
- 13.14.2. Company Revenue
- 13.14.3. Products
- 13.14.4. Recent Developments
13.15. Trinity Biotech
- 13.15.1. Company Overview
- 13.15.2. Company Revenue
- 13.15.3. Products
- 13.15.4. Recent Developments
13.16. Zeus Scientific
- 13.16.1. Company Overview
- 13.16.2. Company Revenue
- 13.16.3. Products
- 13.16.4. Recent Developments
13.17. Abbott Laboratories
- 13.17.1. Company Overview
- 13.17.2. Company Revenue
- 13.17.3. Products
- 13.17.4. Recent Developments
13.18. Beckman Coulter Inc.
- 13.18.1. Company Overview
- 13.18.2. Company Revenue
- 13.18.3. Products
- 13.18.4. Recent Developments
13.19. Bio-Rad Laboratories Inc.
- 13.19.1. Company Overview
- 13.19.2. Company Revenue
- 13.19.3. Products
- 13.19.4. Recent Developments
13.20. Hemagen Diagnostics Inc.
- 13.20.1. Company Overview
- 13.20.2. Company Revenue
- 13.20.3. Products
- 13.20.4. Recent Developments
13.21. Others
- 13.21.1. Company Overview
- 13.21.2. Company Revenue
- 13.21.3. Products
- 13.21.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies